MGRX
MGRX
NASDAQ · Retail

Mangoceuticals Inc

$0.43
-0.06 (-12.23%)
Financial Highlights (FY 2026)
Revenue
4.13M
Net Income
-58,439,372
Gross Margin
61.7%
Profit Margin
-1,413.6%
Rev Growth
D/E Ratio
0.01
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 61.7% 61.9% 61.9% 61.9%
Operating Margin -1,411.6% 6.5% 7.0% 6.0%
Profit Margin -1,413.6% 5.0% 4.5% 3.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 4.13M 5.11M 4.81M 4.75M
Gross Profit 2.55M 3.17M 2.98M 2.94M
Operating Income -58,353,930 329.9K 336.3K 284.7K
Net Income -58,439,372 256.0K 217.7K 186.7K
Gross Margin 61.7% 61.9% 61.9% 61.9%
Operating Margin -1,411.6% 6.5% 7.0% 6.0%
Profit Margin -1,413.6% 5.0% 4.5% 3.9%
Rev Growth +16.3% +24.4% +7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 32.2K 1.50M 1.33M 1.63M
Total Equity 2.98M 4.93M 5.02M 5.16M
D/E Ratio 0.01 0.30 0.27 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -53,512,414 529.0K 487.2K 485.9K
Free Cash Flow 212.8K 148.5K 125.6K